CLINICAL TRIAL: ACTION TO CONTROL CARDIOVASCULAR RISKS IN DIABETES (ACCORD)

这个子项目是许多利用 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 雅阁试验旨在评估控制血糖、血压和血脂（血液中的脂肪）的不同方法对降低2型糖尿病（成人发病）成人心脏病和中风风险的影响。 将从美国和加拿大的约60家研究中心共入组10，000例受试者。 主要结局是首次发生重大心血管疾病事件。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The ACCORD Trial is designed to evaluate the effect of different ways to control blood sugar, blood pressure, and blood lipids (fats in the blood) to reduce the risk of heart disease and stroke in adults with Type 2 (adult-onset) diabetes. A total of 10,000 participants will be enrolled from approximately 60 sites across the USA and Canada. The primary outcome is the first occurrence of a major cardiovascular disease event.